John D. Irvin

1.5k total citations
30 papers, 955 citations indexed

About

John D. Irvin is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Pharmacology. According to data from OpenAlex, John D. Irvin has authored 30 papers receiving a total of 955 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 11 papers in Cardiology and Cardiovascular Medicine and 4 papers in Pharmacology. Recurrent topics in John D. Irvin's work include Blood Pressure and Hypertension Studies (7 papers), Protein Hydrolysis and Bioactive Peptides (5 papers) and Renin-Angiotensin System Studies (5 papers). John D. Irvin is often cited by papers focused on Blood Pressure and Hypertension Studies (7 papers), Protein Hydrolysis and Bioactive Peptides (5 papers) and Renin-Angiotensin System Studies (5 papers). John D. Irvin collaborates with scholars based in United States, Japan and Belgium. John D. Irvin's co-authors include Ronald D. Smith, Peter H. Vlasses, Kristine Prendergast, William J. Greenlee, Michael R. Goldberg, Ruth R. Wexler, Pieter B.M.W.M. Timmermans, Brian N. Swanson, Roger K. Ferguson and Richard O. Davies and has published in prestigious journals such as Stroke, The American Journal of Medicine and Journal of Medicinal Chemistry.

In The Last Decade

John D. Irvin

30 papers receiving 882 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John D. Irvin United States 14 384 271 177 147 88 30 955
Bruce H. Migdalof United States 17 270 0.7× 324 1.2× 78 0.4× 87 0.6× 130 1.5× 39 1.0k
K. J. Kripalani United States 14 189 0.5× 227 0.8× 54 0.3× 90 0.6× 61 0.7× 25 700
William B. Abrams United States 18 263 0.7× 265 1.0× 32 0.2× 102 0.7× 55 0.6× 51 926
Roger K. Ferguson United States 22 461 1.2× 282 1.0× 23 0.1× 148 1.0× 121 1.4× 71 1.2k
Peter Bühlmayer Switzerland 12 440 1.1× 334 1.2× 188 1.1× 182 1.2× 25 0.3× 15 882
Brunner Hr Switzerland 13 761 2.0× 269 1.0× 31 0.2× 363 2.5× 107 1.2× 75 1.2k
Kenneth L. Duchin United States 17 383 1.0× 226 0.8× 21 0.1× 113 0.8× 63 0.7× 43 1.0k
Neville F. Ford United States 17 549 1.4× 71 0.3× 106 0.6× 227 1.5× 25 0.3× 32 954
Paulette A. Lyle United States 19 563 1.5× 256 0.9× 218 1.2× 367 2.5× 70 0.8× 42 1.3k
E. Jähnchen Germany 22 453 1.2× 238 0.9× 62 0.4× 84 0.6× 189 2.1× 91 1.5k

Countries citing papers authored by John D. Irvin

Since Specialization
Citations

This map shows the geographic impact of John D. Irvin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John D. Irvin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John D. Irvin more than expected).

Fields of papers citing papers by John D. Irvin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John D. Irvin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John D. Irvin. The network helps show where John D. Irvin may publish in the future.

Co-authorship network of co-authors of John D. Irvin

This figure shows the co-authorship network connecting the top 25 collaborators of John D. Irvin. A scholar is included among the top collaborators of John D. Irvin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John D. Irvin. John D. Irvin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Melin, Jeffrey M., et al.. (2004). A Consumer Use Study of Over-the-Counter Lovastatin (CUSTOM). The American Journal of Cardiology. 94(10). 1243–1248. 25 indexed citations
2.
Weber, Michael A., Allan I. Goldberg, Elizabeth P. Faison, et al.. (1994). Extended-release felodipine in patients with mild to moderate hypertension. Clinical Pharmacology & Therapeutics. 55(3). 346–352. 10 indexed citations
3.
Greenspon, Arnold J., et al.. (1989). Comparison of intravenous tocainide with intravenous lidocaine for treating ventricular arrhythmias. 10(1). 55–59. 1 indexed citations
4.
Rucinska, Ewa, Roy S. Small, & John D. Irvin. (1989). High-risk patients treated with enalapril maleate: safety considerations. International Journal of Cardiology. 22(2). 249–259. 6 indexed citations
5.
Rucinska, Ewa, Roy S. Small, Donald L. Snyder, et al.. (1989). Tolerability of Long Term Therapy with Enalapril Maleate in Patients Resistant to Other Therapies and Intolerant to Captopril. Drug Safety. 4(2). 144–152. 12 indexed citations
6.
Шапиро, Д. А., et al.. (1987). Enalapril and Hydrochlorothiazide as Antihypertensive Agents in the Elderly. Journal of Cardiovascular Pharmacology. 10. 160–162. 10 indexed citations
7.
Oparil, Suzanne, et al.. (1987). Antihypertensive Effect of Enalapril in Essential Hypertension: Role of Prostacyclin. The American Journal of the Medical Sciences. 294(6). 395–402. 13 indexed citations
8.
Irvin, John D., et al.. (1986). Safety profiles of the angiotensin converting enzyme inhibitors captopril and enalapril. The American Journal of Medicine. 81(4). 46–50. 65 indexed citations
9.
Davies, Richard O., et al.. (1984). Enalapril Worldwide Experience. The American Journal of Medicine. 77(2). 23–35. 84 indexed citations
10.
Swanson, Brian N., Peter H. Vlasses, R Ferguson, et al.. (1984). Influence of Food on the Bioavailability of Enalapril. Journal of Pharmaceutical Sciences. 73(11). 1655–1657. 47 indexed citations
11.
Rotmensch, Heschi H., Peter H. Vlasses, Brian N. Swanson, et al.. (1984). Antihypertensive efficacy of once daily MK-521, a new nonsulfhydryl angiotensin-converting enzyme inhibitor. The American Journal of Cardiology. 53(1). 116–119. 26 indexed citations
12.
Vlasses, Peter H., et al.. (1984). Indacrinone: Natriuretic and Uricosuric Effects of Various Ratios of Its Enantiomers in Healthy Men. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 4(5). 272–277. 10 indexed citations
13.
Irvin, John D., et al.. (1984). BIOAVAILABILITY OF ENALAPRIL MALEATE. 33. 248–252. 14 indexed citations
14.
Vlasses, Peter H., et al.. (1983). Comparative Antihypertensive Effects of Enalapril Maleate and Hydrochlorothiazide, Alone and in Combination. The Journal of Clinical Pharmacology. 23(5-6). 227–233. 27 indexed citations
15.
Vlasses, Peter H., R Ferguson, John D. Irvin, et al.. (1982). Synergistic antihypertensive effect of MK-421 and hydrochlorothiazide. The American Journal of Cardiology. 49(4). 923–923. 3 indexed citations
16.
Osterholm, Jewell L., et al.. (1980). The influence of the adrenal glands upon acute spinal cord injury. Life Sciences. 26(19). 1627–1632. 4 indexed citations
17.
Irvin, John D., et al.. (1980). Comparison of oral indacrinone with furosemide. Clinical Pharmacology & Therapeutics. 28(3). 376–383. 8 indexed citations
18.
Osterholm, Jewell L., et al.. (1979). Influence of Arterial Blood Pressure upon Central Hemorrhagic Necrosis after Severe Spinal Cord Injury. Neurosurgery. 4(1). 53–55. 10 indexed citations
19.
Simeone, Frederick A., et al.. (1979). Role of adrenergic nerves in blood-induced cerebral vasospasm.. Stroke. 10(4). 375–380. 9 indexed citations
20.
Osterholm, Jewell L., et al.. (1973). Anti-norepinephrine Therapy Against Traumatic Hemorrhagic Necrosis of the Spinal Cord: Preliminary Report. Neurosurgery. 20(Supplement 1). 382–399. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bruce H. Migdalof Breakdown of academic impact, for papers by K. J. Kripalani Breakdown of academic impact, for papers by William B. Abrams Breakdown of academic impact, for papers by Roger K. Ferguson Breakdown of academic impact, for papers by Peter Bühlmayer Breakdown of academic impact, for papers by Brunner Hr Breakdown of academic impact, for papers by Kenneth L. Duchin Breakdown of academic impact, for papers by Neville F. Ford Breakdown of academic impact, for papers by Paulette A. Lyle Breakdown of academic impact, for papers by E. Jähnchen
Rankless by CCL
2026